How should I manage persistent pes anserine bursitis with swelling and pain after a partial knee replacement performed 5 years ago, given that I have already received four corticosteroid injections and my provider is reluctant to treat it?

Management of Persistent Pes Anserine Bursitis After Partial Knee Replacement

Given your persistent symptoms after four corticosteroid injections over 5 years, you should pursue alternative injection therapies—specifically oxygen-ozone or prolotherapy (dextrose)—as these demonstrate superior long-term efficacy compared to repeated corticosteroids, or consider PRP therapy if available. 1

Why Move Beyond Corticosteroids

You've reached the practical limit of corticosteroid utility. While corticosteroids provide excellent short-term relief (1-2 weeks), they have significant limitations:

• Recurrence rates of 20-40% with repeated use 2
• Effectiveness diminishes after 8 weeks compared to alternative biologics 1
• General consensus limits injections to 3-4 per year in the same location 3
• In prosthetic joints specifically, corticosteroid injections carry a 0.6% infection risk and should be avoided in routine practice 3

The fact that you've needed four injections over 5 years suggests corticosteroids are providing only temporary relief without addressing the underlying inflammation.

Recommended Treatment Algorithm

First-Line Alternative: Oxygen-Ozone or Prolotherapy

These should be your next step based on the most recent high-quality evidence:

• Oxygen-ozone injection showed statistically significant improvement that lasts longer than corticosteroids (sustained benefit at 8 weeks) 1
• Prolotherapy (20% dextrose) demonstrated similar long-term efficacy to oxygen-ozone 1
• Both options showed better durability than corticosteroids in head-to-head randomized trials 1

Second-Line Alternative: Platelet-Rich Plasma (PRP)

If oxygen-ozone or prolotherapy aren't available:

• PRP combined with hyaluronic acid shows improved pain relief and reduced recurrence in refractory bursitis 2
• However, one 2023 study found corticosteroids superior to PRP at both 1 and 8 weeks 4, creating some controversy
• The 2025 systematic review suggests PRP is most valuable in cases resistant to corticosteroids 2

Third-Line: Extracorporeal Shockwave Therapy (ESWT)

• Less effective than both corticosteroids and PRP in comparative trials 4
• Consider only if injection therapies have failed or are contraindicated

Critical Considerations for Post-Surgical Patients

Your partial knee replacement status creates additional concerns:

• Injecting near prosthetic joints requires strict screening for prosthetic infection before any injection 3
• The infection risk, while low (0.6%), is serious enough that orthopedic surgeons should be involved in the decision 3
• Ultrasound guidance is essential to ensure accurate delivery and avoid prosthetic contamination 3

When Conservative Measures Fail: Surgical Option

If you've exhausted injection therapies, arthroscopic debridement is a definitive option:

• Low recurrence rate (0% in one series) 5
• Minimal complications (3.3%) compared to open surgery (70%) 5
• Particularly appropriate given your history of multiple failed injections 5

Common Pitfalls to Avoid

1. Don't accept indefinite corticosteroid cycling—you've already demonstrated this approach isn't providing durable relief
2. Ensure ultrasound guidance for any injection given your prosthetic joint 3
3. Avoid immobilization after injection; normal activity after 24 hours is appropriate 3
4. Monitor for infection signs more carefully than in native joints 3

Addressing Your Provider's Reluctance

Your provider's hesitancy may stem from:

• Appropriate concern about infection risk near prosthetic joints
• Unfamiliarity with alternative biologic therapies
• Uncertainty about long-term management

Request referral to a sports medicine specialist or interventional pain physician who regularly performs these alternative injection therapies and can coordinate with your orthopedic surgeon regarding prosthetic joint safety protocols.